Blends of cross-linked high amylose starch/pectin loaded with diclofenac  by Soares, Grazielle Arantes et al.
BG
F
A
a
A
R
R
A
A
K
P
H
P
R
T
X
1
c
s
a
a
m
t
&
W
M
2
w
s
r
s
2
c
a
w
a
a
p
r
0
hCarbohydrate Polymers 91 (2013) 135– 142
Contents lists available at SciVerse ScienceDirect
Carbohydrate  Polymers
jo u rn al hom epa ge: www.elsev ier .com/ locate /carbpol
lends  of  cross-linked  high  amylose  starch/pectin  loaded  with  diclofenac
razielle  Arantes  Soares, Ana  Dóris  de  Castro, Beatriz  S.F.  Cury, Raul  C.  Evangelista ∗
aculdade de Ciências Farmacêuticas, Departamento de Fármacos e Medicamentos, Universidade Estadual Paulista – UNESP, Rodovia Araraquara-Jaú, km 1, CEP 14801-902,
raraquara, SP, Brazil
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 14 March 2012
eceived  in revised form 3 July 2012
ccepted 3 August 2012
vailable online 10 August 2012
a  b  s  t  r  a  c  t
Polymers  blends  represent  an  important  approach  to  obtain  materials  with  modulated  properties  to
reach  different  and  desired  properties  in designing  drug  delivery  systems  in order  to  fulﬁll  therapeutic
needs.  The  aim of  this  work  was  to evaluate  the  inﬂuence  of  drug  loading  and  polymer  ratio  on  the
physicochemical  properties  of  microparticles  of  cross-linked  high  amylose  starch–pectin  blends  loaded
with  diclofenac  for  further  application  in  controlled  drug  delivery  systems.  Thermal  analysis  and  X-ray
diffractograms  evidenced  the occurrence  of  drug–polymer  interactions  and  the  former  pointed  also  toeywords:
ectin
igh amylose starch
olymer  blends
heology
hermal  analysis
an  increase  in  thermal  stability  due  to drug  loading.  The  rheological  properties  demonstrated  that  drug
loading  resulted  in  formation  of  weaker  gels  while  the  increase  of  pectin  ratio  contributes  to  origin
stronger  structures.
© 2012 Elsevier Ltd. Open access under the Elsevier OA license.-ray  diffraction
. Introduction
Drug delivery is a broad ﬁeld of research in the pharma-
eutical sciences, for which the development of novel materials
uitable to aid in controlling the drug release according to ther-
peutic needs plays an important role. In this sense, blends of
lready known polymers represent a rational approach to obtain
aterials with different and modulated properties that enable
heir use for speciﬁc goals (Carbinatto, Castro, Cury, Magalhães,
 Evangelista, 2012; Ebube & Jones, 2004; Lecomte, Siepmann,
alther, MacRae, & Bodmeier, 2005; Patel & Patel, 2007; Prezotti,
eneguin, Evangelista, & Cury, 2012; Wang, Hu, Du, & Kennedy,
010). This approach can be advantageous, since apart from
orking with well known substances, it avoids the high cost of
ynthesizing new materials. Additionally, the changes in polymer
atio can result in a wide range of physicochemical properties that
hould provide different drug delivery patterns (Lecomte et al.,
005). Starch is one of the most abundant available polymers and
an be obtained from a variety of sources. It is constituted by
mylose, representing the linear fraction of the macromolecule,
hile amylopectin is the highly branched fraction. High amylose, modiﬁed starch containing 70% of amylose, has been reported
s possessing improved properties for controlled drug delivery
urposes in relation to conventional starch (Onofre, Wanga, &
∗ Corresponding author. Tel.: +55 16 33016976; fax: +55 16 33016960.
E-mail  addresses: revangel@fcfar.unesp.br,
aulrasec@yahoo.com.br (R.C. Evangelista).
144-8617 ©  2012 Elsevier Ltd. 
ttp://dx.doi.org/10.1016/j.carbpol.2012.08.014
Open access under the Elsevier OA license.Mauromoustkos, 2009; Rioux, Ispas-Szabo, Aït-Kadi, Mateescu, &
Juhász, 2002). Moreover, chemical reactions (esteriﬁcation, ether-
iﬁcation, oxidation) of hydroxyl groups of high amylose starch can
be useful to modulate some of its characteristics, such as solubility,
swelling, rheological properties, ﬁlm formation and biodegradation
rate (Rioux et al., 2002).
Cross-linking  has been shown to be a key technique for
modifying the properties of starches and can be achieved by
adding intra- and intermolecular bonds (Singh, Kaur, & McCarthy,
2007). Sodium trimetaphosphate (STMP), monosodium phosphate,
sodium tripolyphosphate, epichlorohydrin, phosphoryl chloride,
a mixture of adipic acid and acetic anhydride, and vinyl chlo-
ride are the main agents used to cross-link food grade starches
(Wattanchant, Muhammad, Hashim, & Rahman, 2003; Woo  & Seib,
1997; Yeh & Yeh, 1993). High amylose contents combined to physi-
cal and chemical modiﬁcations of this material result, for example,
in products with higher viscosity and in granules that are more
resistant against swelling (Richardson, Jeffcoat, & Shi, 2000; Van
Hung, Maeda, & Morita, 2006).
Many researchers have demonstrated the successful use of
high amylose starches cross-linked by different chemicals, such
as epichlorohydrin and STMP, in the development of controlled
drug delivery systems (Cury, Castro, Klein, & Evangelista, 2009a;
Cury, Castro, Klein, & Evangelista, 2009b; Fang et al., 2008; Lenaerts,
Dumoulin, & Mateescu, 1991; Li et al., 2009; O’Brien, Wang, Vervaet,
& Remon, 2009).
Pectins  are a family of complex polysaccharides constituted
mainly of linearly connected -(1-4)-d-galacturonic acid residues
partially esteriﬁed with methanol. The degree of methoxylation
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DM) is used to classify pectins as high methoxyl pectins (DM > 50)
nd low methoxyl pectins (DM < 50) (Ghaffari, Navaee, Oskoui,
ayatiI, & Raﬁee-Tehrani, 2007; Lutz, Aserin, Wicker, & Garti,
009). They are widely used in the pharmaceutical industry to
ompose hydrophilic matrices in oral controlled release dosage
orms (Sungthongieen, Sriamornsak, Pitaksuteepong, Somsiri, &
uttipipatkhachorn, 2004; Wei, Sun, Wu,  Yin, & Wu,  2006).
In  this work, two polymers with different properties were
lended and submitted to cross-linking process in order to prepare
aterials with distinct properties. The inﬂuence of drug incorpora-
ion on these properties was evaluated by incorporating diclofenac
n the polymer microparticles.
.  Materials and methods
.1.  Materials
Pectin (type LM-506CS, lot: S74431) was provided by CP Kelko
Copenhagen, Denmark), high amylose starch (Hylon VII, lot:
A9140) was obtained from National Starch & Chemical (New
ersey, EUA), sodium trimetaphosphate (lot: 112K1365) was  pur-
hased from Sigma–Aldrich Co. (St. Louis, USA), sodium hydroxide
lot: 6 11648) was supplied by Grupo Química (Rio de Janeiro,
razil), 37% hydrochloric acid (lot: 29957) was provided by Quimis
Diadema, Brazil), ethyl alcohol (lot: 127698) was  obtained from
ynth (Diadema, Brazil), and sodium diclofenac (lot: 061117-1) was
rovided by Henrifarma (São Paulo, Brazil).
.2. Cross-linking reaction
The  cross-linking reaction of polymers blends at different ratios
4:1, 1:1 and 1:4) was performed in alkaline aqueous media and
TMP was used as cross-linker, based on procedure described by
arbinatto et al. (2012) with minor modiﬁcations. Brieﬂy, the poly-
ers blends (5%) were dispersed in pre-heated water at 80 ◦C by
echanical stirring until to reach room temperature. The base (4%
f NaOH pellets) was then added to the dispersion and completely
issolved prior the addition of the solid cross-linker (30% of poly-
er mass). After the dispersion was kept under stirring for 2 h,
 mol  L−1 HCl (about 2%, v/v) was added in order to adjust the pH to
 and to stop the reaction. The samples were washed once with 85%
thanol, then eight times with 65% ethanol and ﬁnally once with
bsolute ethanol and ﬁltered under vacuum.
The samples were labeled according to polymers names HA–P
high amylose–pectin) followed by their respective ratios in the
ixture. The physical mixtures were indicated by the preﬁx PM
hile the sufﬁx WD and CD describe the samples without cross-
inker and the samples containing diclofenac (SD), respectively.
.3.  Drug loading/effect of SD concentration on drug loading
Diclofenac was incorporated into the cross-linked samples
y soaking them into drug solutions at different concentrations
3 mg/mL, 6 mg/mL, 9 mg/mL), under stirring for 30 min at room
emperature. After that, the samples were frozen and dried by
yophilization overnight (−30 ◦C), since, according to previous tests,
he oven-drying was not able to yield powdery product. The drug
ontent and efﬁciency of incorporation were calculated according
o Eqs. (1)–(3). The samples prepared from 9 mg/mL  drug solutions
ere selected for this study because they led to higher efﬁciency of
ncorporation..4. Determination of SD content of the microparticles
An accurately weighed mass of microparticles (about 1 g) was
dded to 50 mL  of water and the dispersion was stirred duringlymers 91 (2013) 135– 142
48  h. The products were then centrifuged at 3500 rpm for 70 min
and the SD concentration in the supernatant was quantiﬁed by
UV absorption at 276 nm on spectrophotometer (Hewlett Packard,
Mod. 8453). The analyses were performed in triplicate and the drug
content was  calculated according to the following equation.
DC  (%) = Aq
Ai
× 100 (1)
where  DC (%) is the drug content (%); Aq is the amount of drug
quantiﬁed in the sample and Ai is the initial amount of drug added
to the sample.
2.5.  Efﬁciency of incorporation
For  the determination of the amount of SD entrapped into the
particles, 10 mL of ethanol were added to an accurately weighed
mass of drug-containing microparticles (about 1 g), stirred for 5 min
and ﬁltered. The drug alcoholic solution was  evaporated at room
temperature to dryness and the residue was redispersed in 25 mL
of puriﬁed water. This dispersion was kept under magnetic stir-
ring (30 min) for complete drug dissolution. The drug concentration
in the supernatant was  quantiﬁed by UV absorption at 276 nm on
spectrophotometer (Hewlett Packard, Mod. 8453) and assumed as
free drug. The tests were performed in triplicate and the efﬁciency
of incorporation was  calculated according to Eqs. (2) and (3).
FD  (%) = Aq
Ai
× 100 (2)
EI  (%) = 100 − FD (3)
FD  (%) is the free drug (%), Aq is the amount of drug quantiﬁed in
the sample and Ai initial amount of drug added to the sample. EI
(%) is the efﬁciency of incorporation.
2.6.  Size and shape properties
Particle  size distribution and shape of samples were analyzed
with a Motic Images Advance 3.2 image analyzer coupled to a Leica
MZ APOTM stereoscope, by measuring Feret’s diameters at 0◦ and
circularity of at least 300 particles at 32-fold magniﬁcation.
2.7. Thermoanalysis
2.7.1. Thermogravimetric analysis (TG) and differential
thermogravimetric analysis (DTG)
TG and DTG curves of samples SD, HA-P 4:1 WD,  HA-P 4:1 CD,
HA-P 1:1 WD,  HA-P 1:1 CD, HA-P 1:4 WD and HA-P 1:4 CD were
recorded with a TA Instruments (SDT 600) under nitrogen atmo-
sphere at heating rate of 10 ◦C/min between 25 and 1200 ◦C for
5 mg  of samples sealed in alumina pans.
2.7.2. Differential scanning calorimetry (DSC)
DSC curves of samples SD, HA-P 4:1 WD,  HA-P 4:1 CD,  HA-P
1:1 WD,  HA-P 1:1 CD, HA-P 1:4 WD,  HA-P 1:4 CD, PM HA-P 4:1
WD and PM HA-P 1:4 WD were registered in a TA Instruments DSC
2910 at heating rate of 10 ◦C/min between 25 and 600 ◦C, under
nitrogen atmosphere (100 mL/min). About 5 mg  of samples sealed
in alumina pan was  used for each measure.
2.8. X-ray diffractionThe  X-ray diffraction analysis of P, HA, SD and samples HA-P
4:1 WD,  HA-P 4:1 CD, HA-P 1:1 WD,  HA-P 1:1 CD, HA-P 1:4 WD  e
HA-P 1:4 CD were performed on a X-ray diffractometer (Siemens® –
Model D5000), using nickel-ﬁltered Cu K radiation (tubeoperating
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Table 1
Average Feret diameter, circularity and residual mass (%) of samples.
Samples Diameter (m) Circularity Residual mass (%)
HA-P 4:1 WD 69.16 ± 21.353 0.730 ± 0.0524 45.76
HA-P 4:1 CD 45.78 ±  21.387 0.716 ± 0.0625 53.74
HA-P 1:1 WD 61.92 ± 19.788 0.756 ± 0.0426 45.50
HA-P 1:1 CD 45.03 ± 20.902 0.704 ± 0.0552 47.27
HA-P 1:4 WD 69.41 ± 21.069 0.742 ± 0.0471 35.19Fig. 1. Size distribution of samples.
t 40 kV and 30 mA). The scanning regions were collected from 4◦
o 60◦ (2) in step size of 0.05 (2).
.9.  Rheological measurements
Polymers  aqueous dispersions (10%) were prepared and their
ynamic viscoelastic properties were measured by using a con-
rolled stress rheometer (Haake Rheostress 1) (Gebruder Haake,
ermany) equipped with cone-plate (C35/2Ti) of 35 mm diame-
er and a gap of 105 m.  A circulating water bath (HAAKE C25P)
or sample temperature control and a software (Rheowin 3) for
ata acquisition were used. All measurements were carried out
n triplicate, within the linear viscoelastic range, at 37 ◦C. In order
o determine the linear viscoelastic region, stress sweeps between
.1 and 100 Pa were performed, at a low frequency (1 Hz). Small
eformation oscillatory experiments were conducted by using two
teps of rheological measurements: (1) frequency sweeps at a con-
tant stress (1 Pa) and angular velocity range of 0.6 to 623 rad/s to
btain mechanical spectra by recording the dynamic moduli G′ and
′′ and (2) creep/recovery tests were carried out at constant stress
1 Pa). In this assay the stress was applied instantly and maintained
or a period of 150 s. After removing the stress, compliance was
easured during further 150 s.
. Results and discussion
.1.  Drug loading and efﬁciency of incorporation
The drug loading was  not signiﬁcantly inﬂuenced by both poly-
er ratio and drug concentration in solution, since all samples
resenting high drug level (92–98%). However, the highest efﬁ-
iency of incorporation of SD into microparticles was obtained from
 mg/mL  SD solutions, which were then selected for the preparation
f samples for further analysis.
.2.  Size and shape properties
Drug  incorporation led to a decreasing of particle size, since
D samples presented a highest percentage of particles in small-
st size ranges, as can be seen in size distribution proﬁles (Fig. 1).
his behavior indicates that drug incorporation resulted in a more
acked network due to drug–polymer interactions. The Feret’s
iameter establishes a quantitative analysis of particle size and is
eﬁned as the distance between two parallel tangents of the parti-
le at an arbitrary angle (Boschetto & Giordano, 2012). Their average
alues (Table 1) conﬁrmed the tendency of decrease of size due to
he drug addition.HA-P 1:4 CD 42.61 ± 18.558 0.720 ± 0.0539 35.52
Circularity is a two-dimensional geometric tolerance that con-
trols how much a feature can deviate from a perfect circle deﬁned
by the value 1 (Jones et al., 2008). The high circularity of the sam-
ples, 0.704 and 0.756 (Table 1), and the narrow variation between
the values demonstrate their shape regularity (Goyanes, Souto, &
Martínez-Pacheco, 2011; Tunón, Börjesson, Frenning, & Alderborn,
2003).
3.3. Thermoanalyses
TG  and DTG curves of SD (Fig. 2) show an initial peak at 65 ◦C,
which should be related to moisture evaporation (Bartolomei,
Rodomonte, Antoniella, Minelli, & Bertocchi, 2007). A second and
main peak (about 30% of mass loss) occurs in three steps among
270–375 ◦C and it can be attributed to SD melting and decom-
position (Sipos, Szücs, Szabó, Ero˝s, & Szabó-Révész, 2008). The
TG/DTG curves of samples HA-P 4:1 WD,  HA-P 4:1 CD, HA-P 1:1
WD, HA-P 1:1 CD, HA-P 1:4 WD,  HA-P 1:4 CD (Fig. 2) show a
ﬁrst peak about 40–110 ◦C attributed to moisture evaporation,
as it has been reported for others polysaccharides (Einhorn-Stoll,
Kunzek, & Dongowski, 2007; Godeck, Kunzek, & Kabbert, 2001; Shi
& Gunasekaran, 2008). The main peak was  observed between 180
and 400 ◦C and the relative intensity of this peak was higher for
samples CD than for samples WD,  suggesting the occurrence of both
polymer degradation and drug melting, since these events occur in
the same temperature range and probably are integrated. The CD
thermograms showed a discrete shoulder between 210 and 220 ◦C
that indicates the decomposition of more than one substance. The
presence of this shoulder unchanged in the thermoanalytical proﬁle
once again suggests physicochemical interactions between drug
and polymer (Mora, Longhi, & Granero, 2010).
Sample 1:4 WD (Fig. 2) shows a peak at 134 ◦C, which can result
from loss of chemical bonded water (Shi & Gunasekaran, 2008).
The presence of this event only in this sample can be attributed to
the higher proportion of pectin, which is the most crystalline poly-
mer. Another peak above 900 ◦C can be observed in thermograms
of samples WD,  indicating that the drug incorporation promoted
the increase of thermal stability, a fact that is conﬁrmed by higher
residual mass (%) of samples CD (Table 1). The drug–polymer inter-
action should have also improved thermal stability of SD, since its
decomposition peak at 800 ◦C is not present in thermograms of
CD samples. The overall modiﬁcations in thermal behavior of sam-
ples WD and CD should be attributed to the structural differences
promoted by drug–polymer interactions.
The DSC curve of SD (Fig. 3) shows a ﬁrst little endothermic event
at 65 ◦C which must be related to the moisture evaporation and the
next well deﬁned endothermic peak around 290 ◦C related to drug
melting (280–294 ◦C). The exothermic peak (300 ◦C) is attributed
to the decomposition by oxidation reaction (Puttipipatkhachorn,
Pongjanyakul, & Priprem, 2005; Szüts, Budai-Szücs, Erõs, Otomo, &
Szabó-Révésza, 2010). The DSC curves of PM are depicted in Fig. 3,
in which there are three endothermic peaks between 90 and 400 ◦C.
The ﬁrst, around 100 ◦C, can be related to moisture evaporation in
agreement with TG/DTG achievements, while the second one, about
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00 ◦C, should be attributed to depolymerization of pectin chains,
hich is conﬁrmed by the highest intensity of this peak in the
ample with the greatest pectin amount (PM HA-P 1:4) (Einhorn-
toll et al., 2007; Shi & Gunasekaran, 2008). The third peak
bove 244 ◦C is attributed to the high amylose starch degradation
Massicotte, Baille, & Mateescu, 2008).
The DSC curves of samples WD and CD (Fig. 3) showed simi-
ar proﬁles; nevertheless, samples CD showed a decrease of Tm of
olymer in relation to samples WD.  In addition, the endothermic
nd exothermic peaks of diclofenac are absent in CD samples. Both
vents indicate that SD is molecularly dispersed within the polymer
atrix, building a solid solution (Sipos et al., 2008).
The change in the Tm of the polymer should also be attributed
o morphological modiﬁcations experienced by polymer matrix,
uch as the size of crystallites and the crystallinity degree due to
rug–polymer interactions (Devine et al., 2006).
.4. X-ray diffraction
The  diffractogram patterns of samples (SD, HA, P, HA-P 4:1 WD,
A-P 4:1 CD, HA-P 1:1 WD,  HA-P 1:1 CD, HA-P 1:4 WD,  HA-P 1:4
D) are exhibited in Fig. 4. The high amylose starch (HYLON VII®)
iffractogram shows characteristic peaks of B structure around 17◦,
9◦, 23◦ and 25◦ (2) (Freire, Fertig, Podczeck, Veiga, & Sousa, 2009;
ishra, Datt, & Banthia, 2008). The pectin diffractogram presents
ntense and well deﬁned peaks at 12.7◦, 18.42◦, 25.32◦ and 40.14◦
2), showing its crystalline structure (Mishra et al., 2008).
For  all HA–P mixing ratios in WD microparticles, the character-
stic peaks of high amylose starch and pectin are absent, behavior
hat can be attributed to the amorphization of samples due to
he lyophilization process (Mora et al., 2010) and to the struc-
ural reorganization promoted by the cross-linking reaction. The
D diffractogram exhibits signiﬁcant peaks characteristic of this
rug around 15.39◦, 17.42◦ and 27.24◦ (2) (Fini, Moyano, Ginés,ysis (TG/DTG) of samples.
Martinez-Perez, & Rabasco, 2005). The disappearance of SD peaks in
CD microparticles, mainly at low values of 2, should be result from
the destruction of the crystalline structure, which involves changes
in both crystallites size and crystallinity degree (Devine et al., 2006).
These morphological changes can occur due to progressive amor-
phization and/or dissolution of the drug inside the polymer matrix,
since drug molecules interact with polymer and its original crys-
talline structure becomes deformed (Fini et al., 2005). The set of
X-ray diffraction results reinforce the occurrence of drug–polymer
interactions, as indicated by thermal analysis data.
3.5.  Rheological properties
The  mechanical spectra data can be used to classify the structure
of gels as weak or strong (Martínez-Ruvalcaba, Chornet, & Rodrigue,
2007). The mechanical spectra of WD and CD microparticles are
shown in Fig. 5, in which it can be observed that G′ values remained
higher than G′′ values within the whole frequency range explored
and the values were quasi parallel, displaying the elastic gel behav-
ior of all materials. In addition, both samples WD  and CD behaved
as strong or true gel, characteristic of covalently cross-linked net-
works, since G′ values were nearly frequency independent (Grassi,
Lapasin, Grassi, & Colombo, 2006; Martínez-Ruvalcaba et al., 2007;
Rosalina & Bhattacharya, 2002; Szüts et al., 2010; Yoneya, Ishibashi,
Hironaka, & Yamamoto, 2003).
The drug loading did not qualitatively affect the rheological
behavior that remained as gel materials, although both the G′ val-
ues and the difference between G′ and G′′ values were lower than
those exhibited by samples WD,  indicating that the drug addition
resulted in the weakening of the polymer network (Martínez-
Ruvalcaba et al., 2007; Szüts et al., 2010). This decrease of G′
values that demonstrate the less pronounced elastic properties
of gels than their respective WD samples, suggests that the SD
interactions with carboxyl groups of the polymers prevent
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Rees, Thom, & Welsh, 1977).
Analogously, samples WD built stronger gels, according to their
low values of n and highest values of S (Table 2), while samples
CD should result in a looser and weaker structure. Besides, the
Table 2
G′ , R(%), n exponent and S values of samples.
Samples G′ (Pa) %R n S
HA-P 4:1 WD 105.21 48.15 0.058 92.94
HA-P 4:1 CD 9.67 11.77 0.358 4.75Fig. 3. DSC c
he original H bond formation between them. Similar behav-
or was related for PAA/PVA hydrogel containing aspirin (Mac
ann, Higginbotham, Geever, & Nugent, 2009) and protein-
olysaccharide systems containing salbutamol (Saxena, Kaloti, &
ohidar, 2011). This weakening of network by drug incorporation
s related to a “plasticizing effect” of the drug that disturbs macro-
olecular interactions of gel network (Franc¸ ois, Rojas, Daraio, &
ernik, 2003).
The  variation of storage modulus (G′) at low frequencies in a
og–log plot of G′ versus ω follows the power law (Saxena et al.,
011), given by:
′ = Sωn (4)
here  G′ is the storage modulus; S the gel strength; ω the oscillation
requency and n is the viscoelastic exponent.The n and S values have shown to be sensitive to the
ross-linking density within the polymer network, allowing a
uantitative estimation of strength of gel structures (Nyström,
alderhaug, Hansen, & Lindman, 1995; Scalan & Winter, 1991; of samples.
Watase,  Nishinari, & Clark, 1989). In this sense, the decrease of
distance is represented by higher S values and an increase of the
cross-linking density, both events related to stronger gel structures.
Inversely, the decrease of n exponent values with increasing of
cross-linking density was  reported in a study with PVA gels (Morris,HA-P 1:1 WD 353.36 41.75 0.154 282.47
HA-P 1:1 CD 72.74 30.50 0.185 51.10
HA-P 1:4 WD 1467.00 73.52 0.142 1095.97
HA-P 1:4 CD 701.66 47.50 0.112 496.80
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ample 1:4 HA-P WD exhibited the highest S values, which must
e attributed to the strongest structures that are closest to covalent
els.
These ﬁndings are in agreement with mechanical spectra data
hat indicate that the drug incorporation resulted in the weakening
f polymer network due to factors previously discussed.The  creep-recovery tests were performed to assist the under-
tanding of the internal structures of these systems that presented
n important elastic behavior as showed by mechanical spec-
ra. The recovery (%) was calculated from Jmax and Jmin valuesatterns of samples.
(Table 2), according to an equation proposed by Ghannam
(2004):
R(%) =
[
Jmax − Jmin
Jmax
]
× 100 (5)
The  highest R% values of 1:4 samples show that WD and CD sam-
ples, containing higher relative amount of pectin, are more elastic
than the others, corroborating the G′ data, demonstrating that the
increase of pectin content allows the formation of stronger and
more elastic gels. Besides, the differences in creep-recovery data
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or samples WD and CD show that internal structures are different
Dolz, Hernandez, & Delegido, 2008), which also should be related
o drug–polymer interactions.
.  Conclusions
The inﬂuence of both drug loading and polymer propor-
ion on microparticles properties was demonstrated and the
rug–polymer interactions were evidenced by the analytical results
resented in this work. In addition, it was demonstrated that the
rug loading resulted in an increase of both thermal stability and
rystallinity degree, but with a decrease of mechanical strength of
he structures. Likewise, the microparticles properties were sensi-
ive to polymer proportion, since the blends with higher levels of
ectin resulted in higher thermal stability, while the rheological
roperties, generally, pointed to the strengthening of the struc-
ures.
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